Methotrexate-Induced Pneumonitis in a Patient with Chronic Chikungunya Arthritis
Open Access
- 1 January 2025
- journal article
- images in-infectious-diseases
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e0136-2025
Abstract
Methotrexate (MTX) is a cornerstone in the treatment of inflammatory arthritis owing to its immunomodulatory effects. Its use has expanded to the management of post-viral inflammatory conditions, including chronic arthritis caused by Chikungunya virus (CHIKV) infection, which may mimic rheumatoid arthritis (RA)1. Although effective, MTX poses a risk of adverse effects, including rare but potentially life-threatening complications such as pneumonitis2,3.Keywords
This publication has 3 references indexed in Scilit:
- The case of methotrexate and the lung: Dr Jekyll and Mr HydeEuropean Respiratory Journal, 2021
- Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and TreatmentFrontiers in Medicine, 2019
- Treatment of Chronic Chikungunya Arthritis With Methotrexate: A Systematic ReviewArthritis Care & Research, 2018